Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank40
3Y CAGR-16.1%
5Y CAGR+5.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-16.1%/yr
Annual compound
5Y CAGR
+5.6%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $190000.00 | -6.9% |
| 2024 | $204000.00 | +9.7% |
| 2023 | $186000.00 | -42.2% |
| 2022 | $322000.00 | +61.8% |
| 2021 | $199000.00 | +37.2% |
| 2020 | $145000.00 | - |